The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

2025 promises to be a tumultuous year for the American healthcare and pharma sector. Increased scrutiny on pricing and the incoming Trump administration will certainly trigger changes, as supply chain ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

Dear Savvy Senior, What types of mental health services does Medicare cover? I struggle with anxiety and depression, and my ...